Back to Treatments

Treatment

Pimavanserin

1
Conditions
2
Trials
2,200
Participants
55%
Average Safety

Condition Evidence

Lewy Body Dementia

2 trials · 2,200 participants

65% effectiveness · 55% safety
Pimavanserin | DFDA